Said Baidas

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

Kurt A. Jaeckle, Surasak Phuphanich, Martin J. van den Bent et al. · British Journal of Cancer · 2001 · 119 citations · Full text

Phase II Evaluation of Thalidomide in Patients With Metastatic Breast Cancer

Said Baidas, Eric P. Winer, Gini F. Fleming et al. · Journal of Clinical Oncology · 2000 · 118 citations

Multicenter Phase II Study of Oral Bexarotene for Patients With Metastatic Breast Cancer

Francisco J. Esteva, John A. Glaspy, Said Baidas et al. · Journal of Clinical Oncology · 2003 · 116 citations

An Open Label Trial of Sustained-release Cytarabine (DepoCyt™) for the Intrathecal Treatment of Solid Tumor Neoplastic Meningitis

Kurt A. Jaeckle, Tracy T. Batchelor, Steven O’Day et al. · Journal of Neuro-Oncology · 2002 · 113 citations